Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
4,701	45.52197	0	male	0	7	872	ARF/MOSF w/Sepsis	ARF/MOSF	0	5	$11-$25k	9	40,904	23,198.3906	26,326	14.5	white	22.5	12	0.843994	0.790894	3	0	0	no	0.8	0.75	no dnr	7	101	7.099609	104	28	36.69531	null	2.5	0.699951	0.699951	138	null	125	21	null	0	0	no(M2 and SIP pres)	0
4,702	67.69897	1	male	0	6	537	COPD	COPD/CHF/Cirrhosis	3	10	under $11k	0	13,530	8,061.7969	8,794	27	white	18.796875	31	0.86499	0.776978	1	1	0	no	0.7	0.6	no dnr	6	103	2.799805	65	24	38.19531	310	2.199707	null	0.799927	137	7.439453	126	8	2,895	null	2	no(M2 and SIP pres)	2
4,703	72.93597	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	1	7	under $11k	0	91,573	50,005.9688	52,111	73	white	58	95	0.007	0.001	6	0	0	no	null	null	no dnr	4	58	10.898438	60	10	38.09375	136.65625	null	null	0.599976	129	7.389648	112	26	670	null	1	<2 mo. follow-up	1
4,704	67.01398	1	female	0	17	414	MOSF w/Malig	ARF/MOSF	1	10	under $11k	0	49,608	30,856.4219	29,589	15.666664	white	29.699219	24	0.368958	0.250977	13	0	0	metastatic	0.2	0.2	dnr after sadm	2	118	13	65	42	37.89844	253.3125	2.599609	1.699951	0.5	142	7.439453	91	13	6,340	1	0	adl>=4 (>=5 if sur)	0
4,705	44.64297	1	female	0	44	842	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	127,319	null	null	32.25	other	23.796875	32	0.85791	0.80896	2	0	0	no	null	null	no dnr	44	53	5.299805	70	24	35.09375	357.125	null	2.299805	1.799805	131	7.489258	82	54	940	null	null	no(M2 and SIP pres)	1.867188
4,706	80.46295	0	female	0	96	868	ARF/MOSF w/Sepsis	ARF/MOSF	0	17	null	41	null	143,812.875	139,211	36.25	white	29.398438	36	0.373962	0.255981	5	0	0	no	0.3	0.1	no dnr	96	155	9.599609	125	36	36.39844	142.84375	null	null	1.399902	128	7.509766	1.399902	26	3,270	null	0	SIP>=30	0
4,707	72.16998	1	female	0	10	42	COPD	COPD/CHF/Cirrhosis	2	16	under $11k	0	10,077	6,900.418	7,553	10	white	18.699219	18	0.807983	0.689941	1	0	0	yes	0.5	0.5	dnr before sadm	-1	85	5.799805	105	24	35.39844	null	null	0.799927	1	143	null	77	13	3,425	0	1	<2 mo. follow-up	1
4,708	60.668	1	male	0	6	40	Lung Cancer	Cancer	1	12	$11-$25k	0	15,007	7,510.8633	3,060	15	white	16.597656	7	0.725952	0.452942	1	0	0	metastatic	null	null	no dnr	6	133	10.398438	135	26	35.59375	270	null	0.5	1.099854	139	7.439453	247	21	3,745	0	null	<2 mo. follow-up	0.494751
4,709	76.41595	1	female	0	7	141	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	13,907	8,406.4141	8,812	14	black	24.796875	48	0.75293	0.674927	1	1	0	no	0.6	0.55	no dnr	7	115	0.799927	70	32	38.19531	288	1.799805	0.699951	2.099609	132	7.359375	106	77	1,445	null	null	null	3.365723
4,710	56.57199	0	female	0	11	867	Lung Cancer	Cancer	1	13	null	0	11,383	7,596.5508	7,687	11	white	25.097656	17	0.541992	0.218994	1	0	0	metastatic	0.7	0.4	no dnr	11	120	6.099609	125	30	35.79688	263.3125	1.199951	3.799805	1.099854	137	7.389648	69	26	3,500	1	1	no(M2 and SIP pres)	1
4,711	28.786	0	female	0	10	867	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	>$50k	0	31,965	20,141.1094	20,082	14	black	27.398438	46	0.869995	0.823975	1	0	0	no	0.7	0.7	no dnr	10	65	1.299805	140	13	38.5	167.5	2.5	4.599609	1.899902	143	7.349609	53	39	1,475	1	1	no(M2 and SIP pres)	1
4,712	75.39197	1	female	0	8	11	Lung Cancer	Cancer	1	12	$25-$50k	0	7,706	5,489.1211	5,390	6.5	white	23	13	0.537964	0.214996	1	0	0	metastatic	0.5	0.3	dnr after sadm	2	60	20.296875	115	28	36.29688	156.65625	2.5	0.399963	0.5	137	7.489258	99	14	1,275	null	0	<2 mo. follow-up	0
4,713	54.18799	0	male	0	20	866	CHF	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	51,179	32,586.8594	33,527	21	white	26.296875	43	0.822998	0.711914	1	1	0	no	0.6	0.55	no dnr	20	153	13.099609	145	12	37.69531	187.5	null	null	1.199951	138	7.479492	141	23	3,055	0	0	no(M2 and SIP pres)	0
4,714	72.68195	1	male	1	20	20	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	$11-$25k	9	96,468	54,964.375	56,554	37	white	20.296875	29	0.797974	0.731934	2	0	0	no	0.2	0.15	dnr after sadm	5	67	16.296875	115	37	36.29688	300	2.899902	1.599854	0.899902	136	7.319336	95	18	1,110	null	0	<2 mo. follow-up	0
4,715	69.14398	1	female	1	48	48	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	81,683	50,131.6562	49,244	26.25	white	38.09375	56	0.420959	0.300964	4	0	0	no	0.6	0.4	dnr after sadm	31	159	12	125	8	38	152.5	3.399902	0.399963	5	145	7.639648	198	102	5,040	null	4	<2 mo. follow-up	4
4,716	25.51399	1	female	1	24	24	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	>$50k	0	214,081	null	null	43.666657	white	24.796875	34	0.85791	0.80896	31	0	0	no	null	null	dnr after sadm	22	120	3.199707	125	10	36	236	2.5	3.299805	0.799927	140	7.329102	121	13	1,165	null	1	<2 mo. follow-up	1
4,717	63.16199	1	female	0	31	49	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	9	46,093	30,062.0469	32,577	23.75	white	28.699219	44	0.645996	0.545898	1	0	0	yes	null	null	no dnr	31	93	15.5	100	22	36.59375	292	null	0.399963	0.799927	140	7.399414	130	21	2,200	null	null	<2 mo. follow-up	2.745606
4,718	76.474	0	male	0	10	865	Colon Cancer	Cancer	1	16	>$50k	0	30,924	17,635.5938	13,814	14	white	17.796875	17	0.781982	0.543945	1	0	0	metastatic	1	1	no dnr	10	113	12.898438	75	29	34.5	270	2.199707	null	2.599609	137	7.349609	49	30	1,145	0	5	no(M2 and SIP pres)	5
4,719	55.35898	1	female	1	18	18	Lung Cancer	Cancer	2	11	$11-$25k	9	20,520	13,153.9531	12,673	15.666664	black	38.195313	28	0.135986	0.007	1	1	0	metastatic	null	null	no dnr	18	85	6.099609	68	14	37.69531	null	3.699707	0.399963	1.399902	144	null	128	16	null	null	null	<2 mo. follow-up	3.756348
4,720	65.23499	0	female	0	7	864	Cirrhosis	COPD/CHF/Cirrhosis	3	8	under $11k	0	5,937	4,279.6328	4,729	5.5	white	15.798828	22	0.821899	0.710938	1	0	0	no	0.8	0.6	no dnr	7	108	12	130	8	35.59375	312	3.899902	0.799927	2.899902	136	7.40918	687	43	1,680	0	0	null	0
4,721	45.142	0	female	0	12	864	Cirrhosis	COPD/CHF/Cirrhosis	2	7	under $11k	0	12,627	8,946.6797	10,156	10.5	other	16.398438	31	0.893921	0.822998	1	0	0	no	0.9	0.6	no dnr	12	165	22.597656	120	27	38.59375	56	2.099609	2.199707	1.799805	142	7.349609	183	28	855	6	3	no(M2 and SIP pres)	3
4,722	63.56497	1	male	0	6	55	CHF	COPD/CHF/Cirrhosis	2	6	under $11k	0	3,223	2,557.2129	2,828	8	white	24.097656	50	0.817993	0.703979	1	0	0	no	null	null	no dnr	6	63	10.099609	131	20	38.19531	308	3.199707	null	0.699951	138	7.459961	169	8	1,100	0	0	<2 mo. follow-up	0
4,723	21.489	0	female	0	6	863	ARF/MOSF w/Sepsis	ARF/MOSF	1	2	null	0	9,570	6,218.1367	6,122	15	black	18.796875	23	0.940918	0.919922	1	1	0	no	1	1	no dnr	6	105	11.398438	115	24	38.09375	134.6875	null	null	1	136	7.439453	131	23	2,720	0	null	no(M2 and SIP pres)	0.494751
4,724	68	1	female	0	5	29	COPD	COPD/CHF/Cirrhosis	2	11	null	0	12,333	null	null	22	white	19.898438	24	0.814941	0.700928	1	0	0	yes	null	null	no dnr	5	108	11.5	105	22	36.69531	260	null	null	0.599976	137	7.459961	136	11	2,705	2	null	<2 mo. follow-up	1.838867
4,725	65.23798	1	male	0	12	574	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	29,142	18,768.1875	18,177	26.5	white	28	58	0.684937	0.591919	1	0	0	yes	0.6	0.4	no dnr	12	33	11.199219	150	36	39.59375	157.5	2.399902	2.599609	3.899902	135	7.369141	38	55	80	null	0	no(M2 and SIP pres)	0
4,726	81.05695	0	male	0	72	861	ARF/MOSF w/Sepsis	ARF/MOSF	1	18	null	0	null	null	null	28.25	white	31.296875	68	0.524902	0.408997	5	1	0	no	0.7	0.5	no dnr	72	65	34.796875	65	22	36.09375	217.5	1.799805	37.59375	4.199219	128	7.359375	97	49	5,465	null	null	null	3.155762
4,727	49.18298	1	male	0	18	41	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	$11-$25k	0	28,282	18,109.2656	17,542	18.666656	white	28.796875	52	0.792969	0.724976	1	1	0	no	0.85	0.75	dnr after sadm	4	73	6.899414	95	26	35.69531	528	null	0.799927	1.899902	140	7.459961	109	62	1,405	0	0	<2 mo. follow-up	0
4,728	83.77496	0	male	0	7	860	COPD	COPD/CHF/Cirrhosis	1	7	under $11k	0	12,501	8,251.3281	8,286	11.5	black	22.199219	41	0.715942	0.557983	1	0	0	no	0.7	0.6	no dnr	7	45	14.798828	105	27	38.89844	182.5	null	1.5	5.899414	129	7.339844	95	82	115	0	0	no(M2 and SIP pres)	0
4,729	63.95297	1	female	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	41	96,337	52,540.7188	47,087	36.5	white	27.097656	42	0.520996	0.404968	11	0	0	no	0.5	0.25	dnr after sadm	3	97	8.699219	76	10	35.59375	null	3.899902	1.199951	1.199951	139	null	82	4	null	null	null	<2 mo. follow-up	2.49707
4,730	69.86395	1	male	0	3	15	COPD	COPD/CHF/Cirrhosis	3	16	under $11k	0	2,876	1,988.1016	1,959	1	black	11.798828	16	0.914917	0.856934	1	0	0	no	0.9	0.65	no dnr	3	140	7.099609	125	10	37.79688	313.3125	2.299805	null	0.599976	129	7.469727	128	5	6,280	0	0	<2 mo. follow-up	0
4,731	52.24899	1	female	0	8	110	Lung Cancer	Cancer	2	15	>$50k	0	6,711	4,352.8633	4,250	5	white	15.699219	13	0.760986	0.507935	1	0	0	metastatic	0.6	0.5	no dnr	8	161	9.798828	50	14	38.69531	366.625	null	null	1.5	152	7.419922	144	12	2,780	2	1	no(M2 and SIP pres)	1
4,732	52.59399	1	male	0	21	276	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$25-$50k	0	56,633	34,006.4062	32,846	26.333328	white	23.097656	25	0.85498	0.804932	1	0	0	no	0.6	0.4	no dnr	21	73	15.599609	105	24	37.89844	226.90625	null	1.099854	0.599976	133	7.40918	122	7	null	null	6	adl>=4 (>=5 if sur)	6
4,733	76.72296	1	female	1	15	15	ARF/MOSF w/Sepsis	ARF/MOSF	3	9	null	0	116,654	67,757.1875	59,338	36	white	44.195313	80	0.13797	0.063995	24	0	0	no	0.2	0.1	dnr after sadm	5	62	6.099609	105	24	37	140	null	1.099854	1.199951	142	7.519531	367	41	6,315	null	3	<2 mo. follow-up	3
4,734	78.09698	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	63,577	null	null	53	white	43.296875	77	0.266968	0.16098	1	1	0	no	null	null	dnr after sadm	8	100	7.599609	64	24	39.29688	null	3.899902	1.399902	0.899902	141	null	92	6	null	null	6	<2 mo. follow-up	6
4,735	76.698	1	male	1	5	5	Coma	Coma	1	16	$25-$50k	61	3,462	2,690.6816	2,795	8	white	16.398438	20	0.507935	0.435974	1	0	0	no	null	null	dnr after sadm	1	113	9.398438	125	10	37.79688	346.625	3.399902	2.099609	1	142	7.449219	190	13	2,990	null	null	<2 mo. follow-up	2.037598
4,736	64.96399	1	male	1	5	5	MOSF w/Malig	ARF/MOSF	2	12	$11-$25k	0	42,713	24,700.4375	22,499	45	white	48.398438	112	0.011	0.002	12	1	0	metastatic	null	null	dnr after sadm	3	113	13.898438	115	26	39.19531	96.65625	null	1.599854	1	142	7.399414	114	18	3,270	null	null	<2 mo. follow-up	2.539551
4,737	53.63397	1	female	0	50	156	MOSF w/Malig	ARF/MOSF	1	14	$11-$25k	0	204,110	114,735.125	101,973	33.25	white	33.09375	54	0.291992	0.181976	13	0	0	metastatic	0.7	0.5	dnr after sadm	24	58	3.399902	105	10	35.5	380	null	3.799805	0.899902	130	7.489258	97	15	1,050	null	0	adl>=4 (>=5 if sur)	0
4,738	72.33099	0	female	0	19	854	ARF/MOSF w/Sepsis	ARF/MOSF	2	5	under $11k	0	34,368	20,941.1094	20,411	16.666656	black	22.5	31	0.803955	0.738892	1	1	0	no	0.7	0.9	no dnr	19	77	5.699219	65	20	36.29688	null	null	0.599976	1.099854	142	null	114	12	3,900	0	0	no(M2 and SIP pres)	0
4,739	45.38498	1	female	1	8	8	MOSF w/Malig	ARF/MOSF	1	null	null	0	43,002	25,865.5781	28,655	21	black	44.796875	75	0.053993	0.017998	9	0	0	metastatic	0.2	0.1	dnr after sadm	7	65	12.599609	85	16	36.39844	null	3.099609	0.699951	1.399902	137	null	97	14	4,025	null	null	<2 mo. follow-up	3.200195
4,740	50.82797	1	male	0	6	18	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	under $11k	0	13,347	8,863.7734	8,565	17	black	29.097656	53	0.781982	0.710938	1	0	0	no	0.8	0.6	no dnr	6	112	18.699219	135	28	36.5	175	2.299805	1.699951	2.5	133	7.299805	220	56	955	0	null	<2 mo. follow-up	0.494751
4,741	75.02795	0	male	0	11	853	COPD	COPD/CHF/Cirrhosis	2	12	$11-$25k	0	24,806	15,019.7969	15,288	18.5	white	30.699219	34	0.611938	0.424988	1	1	0	no	null	null	no dnr	11	112	3.099609	145	67	38.29688	106.10938	3	6.199219	1	138	7.419922	135	9	3,420	0	0	no(M2 and SIP pres)	0
4,742	63.56998	0	female	0	14	853	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	46,649	28,247.2812	32,706	20	white	28.5	50	0.740967	0.659912	1	0	0	no	0.7	0.6	no dnr	14	77	9.199219	120	26	38	323.75	null	1.899902	1.699951	136	7.509766	114	24	3,850	null	0	no(M2 and SIP pres)	0
4,743	76.61597	0	female	0	4	853	CHF	COPD/CHF/Cirrhosis	3	10	null	0	6,633	4,034.3262	3,425	7	white	16.199219	19	0.86792	0.780884	1	1	0	no	0.8	0.6	no dnr	4	112	15.898438	165	46	37.69531	null	3.699707	null	0.899902	138	null	129	23	1,110	0	null	no(M2 and SIP pres)	0.494751
4,744	63.87399	1	female	1	8	8	Coma	Coma	0	null	null	61	179,570	96,443	86,563	50.5	white	33.695313	78	0.065994	0.035995	21	0	0	no	null	null	dnr after sadm	8	63	5.899414	135	10	35.5	220	2.099609	2.899902	2.799805	142	7.509766	374	62	3,760	null	null	<2 mo. follow-up	2.06543
4,745	65.42896	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	3	11	null	0	43,352	25,331.6875	24,829	35	white	27.699219	30	0.668945	0.572998	2	0	0	yes	0.5	0.3	dnr after sadm	9	58	12.099609	110	8	38.29688	340	null	0.5	2.699707	145	7.369141	299	50	5,645	null	0	<2 mo. follow-up	0
4,746	69.008	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	11	$25-$50k	100	20,466	11,629.3125	11,087	32	white	54.796875	102	0	0	2	0	0	no	null	null	dnr after sadm	2	62	18.097656	135	41	38.89844	226.65625	null	0.5	1	132	7.569336	184	17	6,840	null	0	<2 mo. follow-up	0
4,747	77.19397	1	male	1	23	23	ARF/MOSF w/Sepsis	ARF/MOSF	0	9	null	26	216,528	124,308.75	116,326	36.333313	white	27.199219	42	0.477966	0.359985	33	0	0	no	null	null	dnr after sadm	23	100	11.5	74	20	37.59375	123.32812	null	null	1.899902	139	7.289062	66	27	null	null	1	<2 mo. follow-up	1
4,748	62.88797	0	male	0	22	847	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	null	0	140,338	81,788.9375	85,116	31	black	23.597656	48	0.766968	0.692993	10	0	0	no	0.95	0.95	no dnr	22	95	12.5	110	24	37.79688	169.375	null	null	1.199951	136	7.429688	98	21	2,870	null	0	SIP>=30	0
4,749	61.12299	1	female	1	15	15	Coma	Coma	1	14	$25-$50k	94	38,083	22,628.7812	22,674	16	white	25.5	27	0.187988	0.129974	3	0	0	no	0.1	0.1	dnr after sadm	6	125	19.296875	105	26	37.19531	343.4375	3.799805	0.699951	1.399902	137	7.419922	285	36	1,093	null	1	<2 mo. follow-up	1
4,750	43.38098	0	female	0	40	847	ARF/MOSF w/Sepsis	ARF/MOSF	3	16	$25-$50k	41	95,022	60,139.0938	61,095	25.25	black	37	64	0.481995	0.363953	1	0	0	no	0.65	0.6	no dnr	40	50	5	145	40	33.89844	55	4.699219	4.099609	2.299805	152	7.439453	393	25	2,750	null	0	no(M2 and SIP pres)	0
4,751	61.78497	0	male	0	51	847	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	null	100	113,757	66,821.8125	77,115	30	white	28.199219	49	0.276978	0.168976	2	0	0	no	0.2	0.1	dnr after sadm	12	108	6.5	105	26	35.69531	150	null	null	0.5	134	7.319336	80	11	1,390	null	0	adl>=4 (>=5 if sur)	0
4,752	70.02295	1	male	1	12	12	MOSF w/Malig	ARF/MOSF	1	12	under $11k	0	146,048	87,808.8125	88,876	43	black	59.796875	104	0	0	34	0	0	yes	0.2	0.1	dnr after sadm	5	67	11.699219	105	12	38.69531	326.625	2.099609	2.299805	0.599976	130	7.469727	157	17	1,890	null	0	<2 mo. follow-up	0
4,753	66.41199	1	female	1	14	14	MOSF w/Malig	ARF/MOSF	2	7	under $11k	0	29,635	18,554.125	18,661	20.333328	white	27.597656	46	0.448975	0.329956	8	0	0	metastatic	0.4	0.2	no dnr	14	73	11.699219	130	10	37.69531	104	1.5	1.599854	0.699951	136	7.429688	125	11	2,225	null	0	<2 mo. follow-up	0
4,754	67.737	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	44	77,412	43,302.9688	46,105	45	white	32.796875	93	0.372986	0.254944	3	1	0	no	0.3	0.2	dnr after sadm	3	118	10.398438	105	24	37	266.625	null	0.599976	0.799927	134	7.399414	128	9	1,150	null	0	<2 mo. follow-up	0
4,755	46.65598	1	male	0	15	425	CHF	COPD/CHF/Cirrhosis	2	16	null	0	45,527	25,871.6406	26,413	21.666656	black	42	59	0.55188	0.35498	1	0	0	no	0.65	0.55	no dnr	15	95	13.699219	85	20	36	null	null	0.699951	1.099854	138	null	104	18	3,950	0	0	no(M2 and SIP pres)	0
4,756	70.073	1	female	0	5	72	CHF	COPD/CHF/Cirrhosis	4	10	$11-$25k	0	4,990	3,376.4356	3,987	11	black	19.097656	31	0.821899	0.709961	1	1	0	yes	0.7	0.2	no dnr	5	75	12.298828	60	14	36	493.3125	null	null	6.299805	137	7.539062	108	53	0	5	5	null	5
4,757	56.75598	1	male	1	6	6	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	9	31,855	18,527.2031	19,456	35	white	49.296875	84	0.046997	0.014999	1	0	0	yes	0.4	0.2	dnr after sadm	6	80	8	126	22	36	247.59375	3.399902	0.599976	0.599976	132	7.439453	105	6	null	null	0	<2 mo. follow-up	0
4,758	77.17694	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	9	12,136	7,305.8594	6,994	25	white	22.796875	45	0.755981	0.678955	1	0	0	no	0.55	0.5	dnr after sadm	4	135	9.898438	125	38	36.69531	398	2.899902	1.599854	2.299805	136	7.589844	77	28	4,425	null	null	<2 mo. follow-up	2.39209
4,759	64.047	1	female	0	22	716	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	44,905	26,915.875	27,255	21.666656	black	32.398438	52	0.658936	0.56189	1	0	0	no	0.6	0.5	no dnr	22	110	14.199219	95	24	35.79688	null	null	null	0.699951	130	null	85	11	null	null	0	null	0
4,760	56.18298	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	$25-$50k	44	59,066	33,900.4375	29,200	40	white	48.09375	90	0.039993	0.011999	11	0	0	no	0	0	dnr after sadm	3	65	16.898438	125	24	36.5	376	null	null	1.899902	132	7.439453	257	31	1,425	null	1	<2 mo. follow-up	1
4,761	65.31696	0	female	0	67	839	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	null	37	null	105,694.75	107,273	25.5	white	31.699219	37	0.42395	0.304993	6	0	0	no	0.4	0.3	no dnr	67	60	20.597656	125	10	38.39844	276.625	2.399902	null	0.899902	135	7.429688	179	9	990	null	0	no(M2 and SIP pres)	0
4,762	58.198	1	male	1	14	14	Coma	Coma	2	8	$11-$25k	94	35,896	null	null	17	white	19.796875	24	0.428955	0.35498	1	1	0	no	0.05	0.02	dnr after sadm	2	47	12.898438	65	10	38	370	2.699707	5.099609	3.5	128	7.399414	155	63	1,300	null	0	<2 mo. follow-up	0
4,763	56.646	1	male	0	15	74	CHF	COPD/CHF/Cirrhosis	3	11	$11-$25k	0	31,154	18,346.0625	17,082	16.666656	black	35.09375	50	0.655884	0.47998	1	1	0	no	0.9	0.8	no dnr	15	62	23.699219	130	8	36.79688	252.5	null	2.5	1.299805	149	7.399414	212	51	3,885	0	5	adl>=4 (>=5 if sur)	5
4,764	75.94299	1	female	0	22	152	CHF	COPD/CHF/Cirrhosis	3	null	under $11k	0	16,361	12,048.6797	12,880	8.666664	black	23.796875	42	0.771973	0.636963	1	1	0	no	0.8	0.6	no dnr	22	65	17	115	32	36.89844	372	29	1	5.599609	145	7.329102	92	127	3,205	2	1	no(M2 and SIP pres)	1
4,765	57.84799	1	male	0	8	638	Cirrhosis	COPD/CHF/Cirrhosis	2	10	under $11k	0	32,299	20,089.7656	20,786	19.5	white	19	25	0.785889	0.655884	4	0	0	no	0.7	0.7	no dnr	8	117	21.898438	70	24	38.09375	null	3.299805	1.099854	1.199951	135	null	149	17	1,070	1	0	no(M2 and SIP pres)	0
4,766	64.61896	1	male	0	15	25	MOSF w/Malig	ARF/MOSF	1	null	null	0	39,790	26,220	25,733	8.333328	white	24.296875	18	0.521973	0.405945	16	0	0	metastatic	0	0	dnr after sadm	1	69	17.898438	138	22	36.5	null	2.199707	0.699951	0.599976	144	null	203	6	null	null	null	<2 mo. follow-up	2.929199
4,767	64.04895	0	male	0	7	837	CHF	COPD/CHF/Cirrhosis	2	18	>$50k	0	6,522	4,604.7148	4,295	7.5	white	16.5	24	0.895996	0.825928	1	1	0	no	null	null	no dnr	7	71	12.099609	80	24	36.59375	null	2.399902	0.799927	0.799927	135	null	76	9	1,350	0	0	no(M2 and SIP pres)	0
4,768	53.172	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	$11-$25k	0	120,668	67,220.1875	63,222	58	asian	32.796875	45	0.608887	0.50293	23	1	0	no	null	null	dnr after sadm	6	66	9.298828	84	24	37.59375	null	1	3	0.799927	134	null	105	2	2,300	null	1	<2 mo. follow-up	1
4,769	61.54398	1	male	0	11	48	COPD	COPD/CHF/Cirrhosis	2	3	null	0	12,650	7,735.4883	7,142	15	white	19.097656	22	0.823975	0.712891	1	0	0	metastatic	0.6	0.5	no dnr	11	58	10.398438	70	24	34.89844	633.25	null	null	1.5	131	7.509766	238	32	1,400	5	0	<2 mo. follow-up	0
4,770	49.67297	1	female	0	5	11	Colon Cancer	Cancer	1	10	under $11k	0	5,648	null	null	14	black	45.296875	65	0.181976	0.014999	1	0	0	metastatic	0.02	0.02	dnr after sadm	1	73	10.199219	100	20	36.69531	401.625	3.699707	1.099854	0.799927	146	6.919922	195	5	5,230	null	0	<2 mo. follow-up	0
4,771	42.01498	0	male	0	5	835	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	$11-$25k	0	12,763	9,769.4062	11,388	16	white	23.199219	32	0.878906	0.835938	1	0	0	no	0.8	0.8	no dnr	5	72	12	115	24	36.59375	262.9375	null	null	0.899902	140	7.389648	157	21	2,085	null	null	null	2.024414
4,772	67.73999	1	male	0	6	285	Colon Cancer	Cancer	1	12	$11-$25k	0	5,624	3,785.209	3,887	7	white	4.5	12	0.927979	0.829956	1	0	0	metastatic	0.8	0.6	no dnr	6	62	9.398438	135	31	35.69531	223.3125	null	2.299805	1.899902	138	7.429688	69	30	785	0	0	no(M2 and SIP pres)	0
4,773	69.83398	1	female	0	19	581	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	under $11k	0	65,899	38,949.6562	40,096	32	white	22.597656	32	0.810913	0.748901	1	1	0	no	0.5	0.5	no dnr	19	118	10.699219	115	32	38.39844	97.95312	2.399902	1.099854	1.799805	134	7.449219	221	47	1,880	null	1	adl>=4 (>=5 if sur)	1
4,774	49.02399	1	male	0	6	9	Cirrhosis	COPD/CHF/Cirrhosis	4	13	null	0	5,844	3,874.1211	5,229	8	black	21.597656	18	0.824951	0.714966	1	0	0	no	0.8	0.6	no dnr	6	68	18.898438	80	23	35.39844	244	null	null	2.299805	126	7.519531	326	75	3,145	0	0	<2 mo. follow-up	0
4,775	45.24298	0	female	0	18	832	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	67,484	39,542.9375	41,029	18.666656	white	24	40	0.832886	0.776978	6	0	0	no	0.9	0.7	no dnr	18	87	12	75	30	35.69531	181.8125	null	null	1.399902	139	7.359375	206	31	700	null	null	null	2.758789
4,776	58.01498	1	female	1	32	32	ARF/MOSF w/Sepsis	ARF/MOSF	1	6	under $11k	0	265,216	147,972.25	143,792	47	other	30.199219	61	0.691895	0.600952	4	0	0	no	0.1	0.8	dnr after sadm	31	117	21.699219	120	40	38	165	null	null	1.399902	143	7.40918	181	64	2,085	null	6	<2 mo. follow-up	6
4,777	58.20898	0	male	0	44	831	CHF	COPD/CHF/Cirrhosis	1	13	null	0	122,895	79,846.6875	80,763	19	white	18.296875	8	0.894897	0.823975	1	0	0	no	null	null	no dnr	44	89	7.599609	70	16	36	228.5625	4.199219	0.699951	0.799927	143	7.369141	74	10	null	0	0	no(M2 and SIP pres)	0
4,778	78.461	0	male	0	9	829	CHF	COPD/CHF/Cirrhosis	3	12	null	0	25,238	14,528.2891	13,822	22	white	24.097656	48	0.755981	0.61499	1	0	0	no	null	null	no dnr	9	83	12.599609	100	22	36.79688	null	3.699707	null	0.899902	136	null	108	34	null	1	1	no(M2 and SIP pres)	1
4,779	82.98395	1	male	0	9	283	ARF/MOSF w/Sepsis	ARF/MOSF	3	11	under $11k	0	21,437	12,664.7109	12,816	16.5	white	32.09375	52	0.5	0.382996	4	0	0	no	null	null	dnr after sadm	6	112	11.398438	65	35	37.69531	170	null	null	0.599976	137	7.40918	71	8	1,770	0	0	no(M2 and SIP pres)	0
4,780	85.72998	1	male	0	5	372	COPD	COPD/CHF/Cirrhosis	5	13	$25-$50k	0	4,450	null	null	12	white	19.199219	39	0.755981	0.613892	1	1	0	no	0.5	0.3	dnr after sadm	2	43	16.699219	145	27	36.39844	175	2.199707	1.399902	4	139	7.369141	57	105	720	null	2	no(M2 and SIP pres)	2
4,781	78.44495	1	female	1	6	6	Coma	Coma	0	null	null	100	24,018	13,985.0547	12,876	37	black	26.796875	52	0.043999	0.021999	2	0	0	no	null	null	dnr after sadm	1	45	15	80	12	36.79688	146	2.399902	6.299805	2.899902	131	7.459961	240	83	727	null	6	<2 mo. follow-up	6
4,782	74.56799	1	male	0	107	349	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	null	174,840.875	172,957	32.75	white	33.195313	84	0.579956	0.469971	1	1	0	no	null	null	dnr after sadm	65	107	9.099609	84	30	37.69531	518.25	null	0.699951	1.199951	131	7.30957	223	14	1,170	null	null	null	2.84668
4,783	74.09198	0	female	0	11	824	Coma	Coma	0	6	under $11k	55	30,836	19,206.1094	22,714	34	white	21.5	25	0.417969	0.343994	1	0	0	no	0.5	0.5	no dnr	11	58	0.399963	135	31	37.89844	185	2	8.5	4.5	129	7.289062	63	100	440	null	4	adl>=4 (>=5 if sur)	4
4,784	43.13498	0	female	0	55	824	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	null	123,479.062	130,232	30	white	29.398438	71	0.730957	0.646973	29	1	0	no	null	null	no dnr	55	137	29.597656	145	14	36.79688	140	null	null	2.299805	150	7.449219	96	46	4,115	null	3	SIP>=30	3
4,785	52.99899	1	male	1	5	5	MOSF w/Malig	ARF/MOSF	1	12	>$50k	0	43,817	25,759.375	24,727	28	white	35.195313	55	0.250977	0.146973	8	0	0	metastatic	0.1	0	dnr after sadm	5	122	17.199219	115	22	38.89844	292.5625	null	null	1.799805	139	7.40918	251	25	3,165	null	0	<2 mo. follow-up	0
4,786	44.383	1	male	0	11	162	CHF	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	24,372	14,127.7031	12,104	19.5	black	21.097656	18	0.901978	0.835938	1	0	0	no	null	null	no dnr	11	98	1	115	36	35.09375	293.3125	1.299805	11.898438	2.699707	145	7.349609	181	87	915	0	2	no(M2 and SIP pres)	2
4,787	62.771	1	male	0	5	24	Colon Cancer	Cancer	2	18	null	0	5,826	3,842.9121	3,791	7	white	43.59375	59	0.181976	0.014999	1	1	0	metastatic	0.65	0.3	no dnr	5	102	13.298828	95	28	37.29688	128.3125	null	0.799927	7.399414	137	7.439453	100	78	15	4	1	<2 mo. follow-up	1
4,788	57.30298	0	female	0	6	821	COPD	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	6,106	3,974.8887	4,224	8	white	16.097656	23	0.921997	0.86792	1	0	0	no	0.8	0.75	no dnr	6	118	18	102	40	35.09375	142.5	null	null	1.299805	135	7.399414	180	29	3,060	null	null	no(M2 and SIP pres)	2.344727
4,789	69.62396	1	female	1	69	69	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	$11-$25k	0	null	225,678.375	222,615	47	white	31.796875	57	0.557983	0.444946	10	0	0	no	0.1	0.1	dnr after sadm	67	62	11.798828	150	30	36.5	157.5	1.799805	null	0.699951	136	7.359375	95	12	950	null	5	null	5
4,790	33.94897	0	female	0	38	820	ARF/MOSF w/Sepsis	ARF/MOSF	3	9	under $11k	9	70,401	43,772.875	45,305	21.25	white	25.699219	26	0.846924	0.793945	2	0	0	no	0.5	0.5	no dnr	38	133	11.5	85	28	37.59375	null	null	0.599976	1.399902	140	null	109	18	null	null	0	null	0
4,791	80.51495	1	female	1	6	6	Coma	Coma	1	14	null	55	22,544	12,786.2422	17,636	32	white	21.199219	34	0.358948	0.28595	1	0	1	no	0.2	0.15	dnr after sadm	2	57	34.398438	95	31	37.79688	152.5	null	null	2.699707	130	7.419922	56	75	344	null	2	<2 mo. follow-up	2
4,792	64.61298	0	male	0	73	819	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	0	null	127,890.562	134,806	25.5	white	22.398438	18	0.80188	0.735962	4	0	0	no	0.8	0.75	no dnr	73	85	15.398438	55	40	35	182.5	null	null	0.899902	136	7.459961	106	20	2,680	0	0	adl>=4 (>=5 if sur)	0
4,793	61.83197	0	male	0	12	819	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	41	62,594	34,359.5938	31,317	30.5	white	19.296875	39	0.764893	0.689941	2	0	0	no	0.88	0.85	no dnr	12	32	14.599609	35	0	36.79688	140	null	null	3.5	142	7.519531	226	73	0	null	null	null	2.108887
4,794	70.70795	0	male	0	12	818	CHF	COPD/CHF/Cirrhosis	4	12	$25-$50k	0	32,075	20,653.9531	23,694	26	white	30.699219	42	0.667969	0.494995	1	1	0	no	0.6	0.5	no dnr	12	72	20.398438	105	22	37.79688	134.6875	1.899902	1.399902	1.899902	144	7.449219	137	41	2,850	null	0	no(M2 and SIP pres)	0
4,795	69.03998	0	male	0	3	817	CHF	COPD/CHF/Cirrhosis	4	11	$25-$50k	0	2,368	1,803.2598	1,889	7	white	14.798828	6	0.898926	0.830933	1	0	0	no	null	null	no dnr	3	110	16.597656	110	36	39.19531	263.3125	2.299805	3.299805	1.199951	141	7.489258	129	20	1,650	0	null	no(M2 and SIP pres)	0.494751
4,796	66.086	1	male	0	11	548	Lung Cancer	Cancer	1	3	$11-$25k	0	22,257	13,260.1797	12,577	12.5	white	18.597656	24	0.671997	0.372986	1	0	0	metastatic	1	1	no dnr	11	117	6.299805	145	8	39.5	338.0625	3	null	0.5	129	7.509766	199	12	2,750	0	0	no(M2 and SIP pres)	0
4,797	36.181	0	female	0	12	816	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	under $11k	0	25,602	16,377.4219	19,751	22	white	21	17	0.907959	0.875	1	0	0	no	0.9	0.9	no dnr	12	117	20	155	44	39.69531	117	2.399902	4.199219	0.5	144	7.329102	82	5	4,045	0	0	no(M2 and SIP pres)	0
4,798	48.99698	1	male	0	3	97	Colon Cancer	Cancer	3	9	under $11k	0	5,688	3,466.8477	2,897	1	white	15	27	0.865967	0.699951	1	0	0	metastatic	0.9	0.7	no dnr	3	65	8.199219	170	40	38.09375	136	null	null	0.699951	132	7.329102	150	7	2,570	null	null	adl>=4 (>=5 if sur)	1.943359
4,799	67.25299	1	male	1	9	9	COPD	COPD/CHF/Cirrhosis	1	17	$25-$50k	0	37,006	21,821.0156	23,331	29	white	31.898438	46	0.595947	0.405945	6	0	0	no	0.5	0.2	dnr before sadm	-5	42	0.299988	165	26	35.89844	284	null	25.097656	4.599609	141	7.369141	81	132	2,420	null	6	<2 mo. follow-up	6
4,800	51.978	1	female	0	6	347	Lung Cancer	Cancer	1	11	$11-$25k	0	12,753	6,469.1133	3,181	11	white	15.699219	13	0.760986	0.507935	1	0	0	metastatic	1	0.8	no dnr	6	123	22.898438	117	28	36.39844	164.28125	null	0.799927	0.699951	138	7.399414	211	12	1,400	0	null	no(M2 and SIP pres)	0.494751

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.